125 related articles for article (PubMed ID: 37946685)
1. Morphological markers of chromosomal instability as predictors of malignancy in pleural effusion.
Aggarwal P; Handa U; Bhagat R; Aggarwal D
Diagn Cytopathol; 2024 Feb; 52(2):76-81. PubMed ID: 37946685
[TBL] [Abstract][Full Text] [Related]
2. Analysis of morphological markers of chromosomal instability in ascitic fluid.
Tyagi R; Dey P; Uppal R; Rajwanshi A
Diagn Cytopathol; 2015 Oct; 43(10):855-8. PubMed ID: 25611316
[TBL] [Abstract][Full Text] [Related]
3. Increased micronucleus count predicts malignant behavior in pleural effusion fluid.
Kökenek Ünal TD; Çoban İ
Turk J Med Sci; 2018 Apr; 48(2):354-360. PubMed ID: 29714452
[TBL] [Abstract][Full Text] [Related]
4. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
Huang MS; Tsai MS; Hwang JJ; Wang TH
Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Cell Block and Immunohistochemistry in Effusion Cytology.
Batool S; Sadaf S; Chughtai AS; Qasim A; Zafar A; Jamil A
Cureus; 2023 Feb; 15(2):e34958. PubMed ID: 36938247
[TBL] [Abstract][Full Text] [Related]
7. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
[TBL] [Abstract][Full Text] [Related]
9. Utility of nuclear morphometry in effusion cytology.
Ambroise MM; Jothilingam P; Ramdas A
Asian Pac J Cancer Prev; 2014; 15(16):6919-22. PubMed ID: 25169546
[TBL] [Abstract][Full Text] [Related]
10. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
11. Number of mesothelial cells as a measure of adequacy criteria for pleural effusions: A multi-institutional study.
Rodriguez EF; Morris PC; Calsavara V; Pastorello RG; Saieg M
Cytopathology; 2020 May; 31(3):223-227. PubMed ID: 32048382
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
13. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
14. Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks.
Koyi H; Wilander E
Anticancer Res; 2023 Feb; 43(2):669-673. PubMed ID: 36697096
[TBL] [Abstract][Full Text] [Related]
15. Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions.
Lee YC; Knox BS; Garrett JE
Aust N Z J Med; 1999 Dec; 29(6):765-9. PubMed ID: 10677119
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study.
Ak G; Metintas S; Taskın AN; Uzel Sener M; Soyler Y; Yilmaz M; Turna A; Akin Kabalak P; Bilaceroglu S; Koksal D; Yilmaz Demirci N; Sogukpinar O; Boga S; Ercelik M; Karadeniz G; Polat G; Guldaval F; Aka Akturk U; Yilmaz S; Ogan N; Yilmaz S; Esendagli D; Caglayan B; Zeybek A; Durmus Kocak N; Mutlu P; Atinkaya Baytemir C; Sarbay I; Yilmaz U; Metintas M
Lung; 2022 Dec; 200(6):807-815. PubMed ID: 36173482
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite DNA analysis does not distinguish malignant from benign pleural effusions.
Economidou F; Tzortzaki EG; Schiza S; Antoniou KM; Neofytou E; Zervou M; Lambiri I; Siafakas NM
Oncol Rep; 2007 Dec; 18(6):1507-12. PubMed ID: 17982637
[TBL] [Abstract][Full Text] [Related]
19. Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
Fazli Khalaf F; Asadi Gharabaghi M; Balibegloo M; Davari H; Afshar S; Jahanbin B
Int J Biol Markers; 2023 Jun; 38(2):81-88. PubMed ID: 36942429
[TBL] [Abstract][Full Text] [Related]
20. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
Wang M; Zhang Z; Wang X
Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
